| Patent | Date |
|---|
Pharmaceutical Compositions Of Lipase-containing Products, In Particular Of Pancreatin
App 20190275122 - Shlieout; George ; et al. | 2019-09-12 |
Lipase variants for pharmaceutical use
Grant 9,539,311 - Svendsen , et al. January 10, 2 | 2017-01-10 |
Lipase Variants for Pharmaceutical Use
App 20150209414 - Svendsen; Allan ; et al. | 2015-07-30 |
Lipase variants for pharmaceutical use
Grant 9,029,115 - Svendsen , et al. May 12, 2 | 2015-05-12 |
Pharmaceutical Compositions Of Lipase-containing Products, In Particular Of Pancreatin
App 20140302000 - Shlieout; George ; et al. | 2014-10-09 |
Pharmaceutical compositions of lipase-containing products, in particular of pancreation
Grant 8,802,087 - Shlieout , et al. August 12, 2 | 2014-08-12 |
Protease variants for pharmaceutical use
Grant 8,455,235 - Svendsen , et al. June 4, 2 | 2013-06-04 |
Lipase Variants for Pharmaceutical Use
App 20120308543 - Svendsen; Allan ; et al. | 2012-12-06 |
Lipase variants for pharmaceutical use
Grant 8,273,348 - Svendsen , et al. September 25, 2 | 2012-09-25 |
Enzymes For Pharmaceutical Use
App 20120207741 - Svendsen; Allan ; et al. | 2012-08-16 |
Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditions
Grant 8,058,264 - Firnges , et al. November 15, 2 | 2011-11-15 |
Enzymes for pharmaceutical use
App 20110158976 - Svendsen; Allan ; et al. | 2011-06-30 |
Proteases for Pharmaceutical Use
App 20110110910 - Svendsen; Allan ; et al. | 2011-05-12 |
Protease Variants for Pharmaceutical Use
App 20100322915 - Svendsen; Allan ; et al. | 2010-12-23 |
N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions
Grant 7,772,225 - Antel , et al. August 10, 2 | 2010-08-10 |
Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
Grant 7,763,607 - Antel , et al. July 27, 2 | 2010-07-27 |
Proteases for Pharmaceutical Use
App 20100135978 - Svendsen; Allan ; et al. | 2010-06-03 |
Lipase Variants for Pharmaceutical Use
App 20100034797 - Svendsen; Allan ; et al. | 2010-02-11 |
N-sulfamoyl-N'-benzopyranpiperidine compounds and uses thereof
Grant 7,547,708 - Antel , et al. June 16, 2 | 2009-06-16 |
Sulfamate Compounds and Uses Thereof
App 20090104126 - SCHOEN; Uwe ; et al. | 2009-04-23 |
Lipases for Pharmaceutical Use
App 20090047266 - Svendsen; Allan ; et al. | 2009-02-19 |
Proteases for Pharmaceutical Use
App 20080317726 - Svendsen; Allan ; et al. | 2008-12-25 |
Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
App 20070254862 - Antel; Jochen ; et al. | 2007-11-01 |
Use of CBx cannabinoid receptor modulators as potassium channel modulators
App 20070254863 - Antel; Jochen ; et al. | 2007-11-01 |
Methods Of Using Potassium Channel Inhibiting Compounds
App 20070191357 - Antel; Jochen ; et al. | 2007-08-16 |
N-Sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions
App 20070149512 - Antel; Jochen ; et al. | 2007-06-28 |
N-sulfamoyl-N'-benzopyranpiperidine compounds and uses thereof
App 20070117823 - Antel; Jochen ; et al. | 2007-05-24 |
Alkyl carbamate-substituted .beta.-lactones, process for their preparation, and pharmaceutical compositions containing them
Grant 7,074,822 - Antel , et al. July 11, 2 | 2006-07-11 |
Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditions
App 20060128673 - Firnges; Michael ; et al. | 2006-06-15 |
Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditions
App 20050261292 - Antel, Jochen ; et al. | 2005-11-24 |
Pharmaceutical compositions of lipase-containing products, in particular of pancreation
App 20050250817 - Shlieout, George ; et al. | 2005-11-10 |
Novel Medical Uses Of 4,5-dihydro-1h-pyrazole Derivatives Having Cb1- Antagonistic Activity
App 20050239859 - Antel, Jochen ; et al. | 2005-10-27 |
Alkyl carbamate-substituted beta-lactones, process and intermediate products for their preparation, and pharmaceutical compositions containing them
App 20050197386 - Antel, Jochen ; et al. | 2005-09-08 |
Trifluoroacetylalkyl-substituted phenyl, phenol and benzoyl compounds and related methods of treatment
Grant 6,930,207 - Antel , et al. August 16, 2 | 2005-08-16 |
Novel medical combination treatment of obesity involving 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
App 20050143441 - Antel, Jochen ; et al. | 2005-06-30 |
Novel medical uses of compounds showing CB1-antagonistic activity and combination treatment involving said compounds
App 20050124660 - Antel, Jochen ; et al. | 2005-06-09 |
Use of selective CB1-antagonists in medical treatments
App 20050101585 - Antel, Jochen ; et al. | 2005-05-12 |
Novel medical uses of 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
App 20050080125 - Antel, Jochen ; et al. | 2005-04-14 |
Trifluoroacetylalkyl-substituted phenyl, phenol and benzoyl compounds and related methods of treatment
App 20040214901 - Antel, Jochen ; et al. | 2004-10-28 |
Microbial enzyme mixtures useful to treat digestive disorders
App 20040057944 - Galle, Manfred ; et al. | 2004-03-25 |
1,7-fused 1H-indole-2-carboxylic acid-N-(1,4-benzodiazepin-3-yl)amides
Grant 5,010,076 - Waldeck , et al. April 23, 1 | 1991-04-23 |
| 